MONTGOMERY, Texas--(BUSINESS WIRE)--Dec. 19, 2005--Endovasc, Inc. - (OTCBB: EVSC) a Business Development Company focused on acquiring and investing in innovative drug development in the areas of cardiovascular and metabolic medicine, announces results from the Company’s Annual Meeting of Stockholders held on December 16, 2005.
